Medication info
Pariwonjeong 20mg (Rabeprazole Sodium)

Pariwonjeong 20mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
Daewon Biotech Co., Ltd.
Appearance
Pale yellow, round enteric-coated tablet
Packaging
For domestic use - 28 tablets/box [14 tablets/Alu Alu packaging x 2]
Approval status
Active

MFDS item code 201906770 · Approved 2019.09.25 · Insurance code 057600240

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including in combination with eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcer, duodenal ulcer The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the patient has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily regimen is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms have resolved, subsequent symptoms may be controlled using an on-demand regimen of 10 mg once daily as needed. Long-term maintenance therapy for gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this drug 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to each patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Older adults Since hepatic function is often decreased, administer with caution.
Child dose
Safety in children has not been established.

Ingredients

Manufacturer
Daewon Biotech Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including in combination with eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcers
  • duodenal ulcers
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastroesophageal reflux disease
  • gastrointestinal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used for the treatment of gastric ulcers and duodenal ulcers, and helps alleviate symptoms of erosive or ulcerative gastroesophageal reflux disease. It is also applicable for long-term maintenance therapy of gastroesophageal reflux disease. It is effective in antibiotic combination therapy for gastrointestinal ulcer patients infected with Helicobacter pylori, and is also used to treat Zollinger-Ellison syndrome. It is utilized for improving various digestive disorders.

How to take

Adult dose

Gastric ulcer, duodenal ulcer The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the patient has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily regimen is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms have resolved, subsequent symptoms may be controlled using an on-demand regimen of 10 mg once daily as needed. Long-term maintenance therapy for gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this drug 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to each patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Older adults Since hepatic function is often decreased, administer with caution.

Child dose

Safety in children has not been established.

Precautions

This medication should not be used in patients with allergies to certain drugs or components. Patients with allergies to penicillin antibiotics or macrolide antibiotics should also be cautious. Women who are pregnant or nursing should not take this medication. Patients with poor liver function or elderly individuals should use this medication with caution. If any allergic symptoms such as skin rash or itching occur during the use of this medication, it should be discontinued immediately. It is important to undergo regular blood tests and liver function tests to check for abnormalities. Patients with heart or vascular issues should take this medication under caution and gastrointestinal symptoms should be closely monitored. Long-term use may increase the risk of osteoporosis and fractures, thus caution is necessary. Rarely, hypomagnesemia, a decrease in blood magnesium concentration, may occur, so regular testing and supplementation may be necessary for long-term users. Since this medication suppresses stomach acid secretion, it may slightly increase the risk of gastrointestinal infections, and if diarrhea persists, it should be consulted with a doctor. Caution is required when driving or operating machinery as drowsiness or dizziness may occur. There may be interactions with other medications, so it is essential to inform healthcare professionals about any ongoing medications. Particularly when used in combination with antibiotics or antivirals, caution is needed, and it should not be taken with certain medications. This medication should not be chewed or crushed, and it should be swallowed whole. Keep out of reach of children and do not transfer to other containers. There is no specific antidote for overdose, and appropriate treatment should be received depending on the symptoms. Safety in children has not been established, thus caution should be exercised in usage. Prolonged use may lead to vitamin B12 absorption issues, so periodic testing is needed.

Side effects

Rash, urticaria, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, ECG abnormalities, migraine, syncope, angina, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, supraventricular tachycardia, thromboangiitis, vasodilation, QT interval prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal bloating, dyspepsia, belching, nausea, rectal bleeding, bloody stool, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stool, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, taste disturbance, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, seizures, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, weakness, hyperesthesia, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, excess circulating blood volume, limb hypotonia, sensory dullness, decreased grip strength, language confusion, staggering, delirium, spatial disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonicity, neuralgia, single contraction, sweating, alopecia, dry skin, herpes zoster, psoriasis, skin color changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurriness, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, urinary retention, nephrolithiasis, uterine bleeding, polyuria, breast enlargement, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, orchitis, urinary incontinence, interstitial nephritis, edema, elevated total cholesterol, elevated triglycerides, elevated BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, fatigue, weight gain, visual disturbances, loss of appetite, cervical stiffness, photosensitive reactions, hangover effects, weight loss, gout, sudden death, coma, hyperammonemia, rhabdomyolysis, spatial disorientation, delirium, anaphylaxis, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, hemolytic anemia, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reaction, arthralgia, idiopathic renal disease, gynecomastia, interstitial pneumonia, elevated thyroid-stimulating hormone, erythema multiforme, toxic epidermal necrolysis, mucous membrane syndrome, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, cutaneous lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to protect it from air and moisture. Avoid storage in excessively hot or cold places, and store safely between 1 to 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Pale yellow, round enteric-coated tablet

Package unit

For domestic use - 28 tablets/box [14 tablets/Alu Alu packaging x 2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.